Literature DB >> 29774168

Evaluating the potential for maximized T cell redistribution entropy to improve abscopal responses to radiotherapy.

Rachel Walker1, Jonathan D Schoenfeld2, Shari Pilon-Thomas3, Jan Poleszczuk1, Heiko Enderling1,4.   

Abstract

The potential for local radiation therapy to elicit systemic (abscopal) anti-tumor immune responses has been receiving a significant amount of attention over the last decade. We recently developed a mathematical framework designed to simulate the systemic dissemination of activated T cells among multiple metastatic sites. This framework allowed the identification of non-intuitive patterns of T cell redistribution after localized therapy, and offered suggestions as to the optimal site to irradiate in order to increase the magnitude of an immune-mediated abscopal response. Here, we evaluate the potential for such a framework to provide clinical decision making support to radiation oncologists. Several challenges such as efficient segmentation and delineation of multiple tumor sites on PET/CT scans, validation of model prediction performance, and effective clinical trial design remain to be addressed prior to the incorporation of such a tool in the clinical setting.

Entities:  

Year:  2017        PMID: 29774168      PMCID: PMC5949881          DOI: 10.1088/2057-1739/aa7269

Source DB:  PubMed          Journal:  Converg Sci Phys Oncol        ISSN: 2057-1739


  27 in total

1.  Numerical simulation and experimental validation of blood flow in arteries with structured-tree outflow conditions.

Authors:  M S Olufsen; C S Peskin; W Y Kim; E M Pedersen; A Nadim; J Larsen
Journal:  Ann Biomed Eng       Date:  2000 Nov-Dec       Impact factor: 3.934

2.  Validation of a one-dimensional model of the systemic arterial tree.

Authors:  Philippe Reymond; Fabrice Merenda; Fabienne Perren; Daniel Rüfenacht; Nikos Stergiopulos
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-05-08       Impact factor: 4.733

3.  Clinically relevant modeling of tumor growth and treatment response.

Authors:  Thomas E Yankeelov; Nkiruka Atuegwu; David Hormuth; Jared A Weis; Stephanie L Barnes; Michael I Miga; Erin C Rericha; Vito Quaranta
Journal:  Sci Transl Med       Date:  2013-05-29       Impact factor: 17.956

4.  Efficacy of adoptive cell transfer of tumor-infiltrating lymphocytes after lymphopenia induction for metastatic melanoma.

Authors:  Shari Pilon-Thomas; Lisa Kuhn; Sabine Ellwanger; William Janssen; Erica Royster; Suroosh Marzban; Ragini Kudchadkar; Jonathan Zager; Geoffrey Gibney; Vernon K Sondak; Jeffrey Weber; James J Mulé; Amod A Sarnaik
Journal:  J Immunother       Date:  2012-10       Impact factor: 4.456

5.  Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis.

Authors:  Roel J H M Steenbakkers; Joop C Duppen; Isabelle Fitton; Kirsten E I Deurloo; Lambert J Zijp; Emile F I Comans; Apollonia L J Uitterhoeve; Patrick T R Rodrigus; Gijsbert W P Kramer; Johan Bussink; Katrien De Jaeger; José S A Belderbos; Peter J C M Nowak; Marcel van Herk; Coen R N Rasch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-09-28       Impact factor: 7.038

Review 6.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

7.  Abscopal Benefits of Localized Radiotherapy Depend on Activated T-cell Trafficking and Distribution between Metastatic Lesions.

Authors:  Jan T Poleszczuk; Kimberly A Luddy; Sotiris Prokopiou; Mark Robertson-Tessi; Eduardo G Moros; Mayer Fishman; Julie Y Djeu; Steven E Finkelstein; Heiko Enderling
Journal:  Cancer Res       Date:  2016-02-01       Impact factor: 12.701

Review 8.  The mechanism of anti-CTLA-4 activity and the negative regulation of T-cell activation.

Authors:  Jedd D Wolchok; Yvonne Saenger
Journal:  Oncologist       Date:  2008

9.  Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy.

Authors:  Eric A Reits; James W Hodge; Carla A Herberts; Tom A Groothuis; Mala Chakraborty; Elizabeth K Wansley; Kevin Camphausen; Rosalie M Luiten; Arnold H de Ru; Joost Neijssen; Alexander Griekspoor; Elly Mesman; Frank A Verreck; Hergen Spits; Jeffrey Schlom; Peter van Veelen; Jacques J Neefjes
Journal:  J Exp Med       Date:  2006-04-24       Impact factor: 14.307

Review 10.  Combinations of immunotherapy and radiation in cancer therapy.

Authors:  Ralph E Vatner; Benjamin T Cooper; Claire Vanpouille-Box; Sandra Demaria; Silvia C Formenti
Journal:  Front Oncol       Date:  2014-11-28       Impact factor: 6.244

View more
  2 in total

Review 1.  Assessing the interactions between radiotherapy and antitumour immunity.

Authors:  Clemens Grassberger; Susannah G Ellsworth; Moses Q Wilks; Florence K Keane; Jay S Loeffler
Journal:  Nat Rev Clin Oncol       Date:  2019-06-26       Impact factor: 66.675

2.  Mathematical modelling of the synergistic combination of radiotherapy and indoleamine-2,3-dioxygenase (IDO) inhibitory immunotherapy against glioblastoma.

Authors:  Arthur Chakwizira; Jonatan Ahlstedt; Henrietta Nittby Redebrandt; Crister Ceberg
Journal:  Br J Radiol       Date:  2018-05-17       Impact factor: 3.039

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.